期刊文献+

帕罗西汀对心房颤动患者焦虑抑郁情绪生活质量及临床疗效的作用 被引量:2

The effects of paroxetine hydrochloride on quality of life, clinical result of atrial fibrillation patients with anxiety or depression
原文传递
导出
摘要 目的探讨心房颤动(Atrial Fibrillation,Af)患者合并焦虑、抑郁情绪的发生率,观察帕罗西汀对Af患者合并焦虑、抑郁情绪的临床疗效、帕罗西汀治疗后Af患者Af的转归。方法采用汉密顿焦虑量表(HAMA)和汉密顿抑郁量表(HAMD-24)评定Af患者的焦虑、抑郁情绪;采用健康状况调查问卷(SF-36)评定患者的生活质量。将筛查出的合并焦虑、抑郁情绪的Af患者采用随机信封的方法分为盐酸帕罗西汀治疗组和谷维素对照组,分别观察治疗前、后2组患者HAMA、HAMD-24及健康状况的变化以及埘的临床疗效。结果Af患者合并焦虑、抑郁情绪的发生率分别为32.9%、37.2%;帕罗西汀治疗组治疗后HAMA、HAMD-24评分分别为(13.19±5.88)分、(20.57±6.24)分,较对照组[HAMA评分(19.84±5.02)分、HAMD-24评分(29.75±8.63)分]明显降低(P〈0.01),SF-36生活质量评分提高(P〈0.01);阵发性Af、持续性Af的治疗有效率分别为88.8%、75.0%。结论Af患者合并焦虑、抑郁情绪的发生率较高,生活质量差;盐酸帕罗西汀治疗能够改善Af患者的焦虑、抑郁情绪,改善Af患者的生活质量,并有助于控制阵发性盯及持续性Af的症状。 Objective To investigate the prevalence rate of anxiety or depression in patients with atrial fibrillation (Af) disease and the result of influence of paroxetine hydrochloride,including the changes of the health situation and the prognosis of different kinds of Af. Methods Totally 140 patients who underwent Af were assessed with HAMA and HAMD-24 before and after the treatment. 65 patients with anxiety and depression were evaluated with 36-Heahh survey questionnaire (SF-36) and divided into two groups at random,one of which was prescribed paroxetine hydrochloride 20 - 60rag once a day on the basis of routine cardiac drug therapy for 3 months and the other oryzarol tablets. Results The prevalence rate of anxiety and depression in patients with Af was 32.9% ,37.2% respectively. The exponent of HAMA and HAMD-24 in paroxetine hydrochloride group after treatment( HAMA 19.84±5.02, HAMD-24 29.75±8.63 ) was lower than that of before( HAMA 22.35±6.94, HAMD-24 33.79±10.01) ,and lower than that of oryzanol tablets. The scores of SF-36 was higher and the attack frequency of Af after treatment of paroxetine hydrochloride was lower than that of before. The curative rate of paroxetine hydrochloride on paroxysmal Af and permanent Af was 88.8%,75.0%. Conclusion The prevalence rate of anxiety and depression in patients with Af is high. Paroxetine hydrochloride can relieve the symptoms of anxiety and depression in Af patients and control symptoms of paroxysmal Af and permanent Af.
出处 《中国行为医学科学》 CSCD 2008年第11期990-992,共3页 Chinese Journal of Behavioral Medical Science
基金 基金项目:山东省2002年科学技术发展计划(软科学部分)项目[A200215(4)]
关键词 心房颤动 焦虑 抑郁 盐酸帕罗西汀 Atrial Fibrillation Anxiety Depression Paroxetine Hydroehloride
  • 相关文献

参考文献10

  • 1李莉,孙宝贵,谭宁,郭林妮.全国心房颤动规范化治疗研讨会纪要[J].中华心血管病杂志,2007,35(7):684-685. 被引量:4
  • 2Stewart RAH,North FM,West TM, et al. Depression and cardiac morbidity and mortality : cause or consequence? Eur Heart J ,2003,24:2027- 2037.
  • 3Fuster V,Roden LE, CannomDS, et al. ACC/ AHA/ ESC 2006 guidelines for the management of patients with atrial fiMllation -executive summary. Eur Heart J,2006,27 : 1979 -2030.
  • 4张作记.汉密顿焦虑量表//见中国行为医学科学编辑委员会编.行为医学量表手册.北京:中华医学电子音像出版社,2005:213-225.
  • 5方积乾.健康状况调查问卷//见中国行为医学科学编辑委员会编.行为医学量表手册.北京:中华医学电子音像出版社,2005:54-59.
  • 6Fuster V,Roden LE,Cannom DS,et al. ACC/ AHA/ ESC 2006 guidelines for the management of patients wilh atrial fibrillation -executive summary . Eur Heart J,2006,27 : 1979 -2030.
  • 7Thrall G, Lip GY, Carroll D, et al . Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest,2007,132:1259-1264.
  • 8Pappone C, SantinelliV, Manguso F, el al. Pulmonary vein denervation enhances long-term benefit after eireumferenlial ablation for paroxysmal atrial fibrillation. Circulation ,2004,109:327-334.
  • 9Scherlag BJ , Nakagawa H, JackmanWM, et al. Electrical stimulation to identif) neural elements on the heart:their role in atrial fibrillation . J Interv Card Elec rophysiol,2005,13:37-42
  • 10Shirayama T,Sakamolo T, Sakalani T, et ah Usefulness of paroxetine in depressed men with paroxysmal atrial fihrillation. Am J Cardiol,2006, 97:1749-1751.

共引文献6

同被引文献17

  • 1Irving G,Lloyd Williams M. Depression in advanced cancer[J]. Eur J Oncol Nuts,2010,14(5) :395-399.
  • 2Pelletier G,Verhoef M J,Khatri N,et al. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues [J]. J Neurooncol, 2002,57(1) :41-49.
  • 3Low CA,Stanton AL,Bower JE,et al. A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer[J]. Health Psychol, 2010,29 (4) : 460-466.
  • 4Lloyd-Williams M,Shiels C,Taylor F,et al. Depression-an inde pendent predictor of early death in patients with advanced cancer [J]. J Affect Disord,2009,113(1-2) : 127-132.
  • 5Chan CW,Richardson A, Richardson J. An investigation of a symp- tom cluster in Chinese patients with lung cancer receiving radiothera- py[J]. Contemp Nurse,2013,45(2) :164-173.
  • 6Mustafa M, Carson-Stevens A, Gillespie D, et al. Psychological interventions for women with metastatic breast eancer[J]. Co- chrane Database Syst Rev, 2013,6 (6) : D4253.
  • 7Antoni MH, Lutgendorf SK, Blomberg B, et al. Cognitive-behavioral stress management reverses anxiety related leukocyte transcriptional dynamics[J]. Biol Psychiatry, 2012,71(4) : 366-372.
  • 8Semple C, Parahoo K, Norman A, et al. Psychosocial interven- tions for patients with head and neck cancer[J]. Coehrane Data- base Syst Rev,2013,7(7) :D9441.
  • 9曾奇,郭翔,李宁炜,向燕群,曹素梅,洪明晃.313例老年鼻咽癌患者临床特征及预后的回顾性研究[J].癌症,2008,27(3):289-294. 被引量:17
  • 10王成涛,曹卡加,谢国丰,张莹莹,黄培钰.初诊远处转移鼻咽癌临床预后因素分析[J].中华肿瘤防治杂志,2009,16(6):439-442. 被引量:7

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部